Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
about
How we will treat chronic myeloid leukemia in 2016.Characterization of Patients with Chronic Myeloid Leukemia Unresponsive to Tyrosine Kinase Inhibitors Who Underwent Allogeneic Hematopoietic Stem Cell TransplantationManagement of chronic myeloid leukemia in blast crisis.Implementing the EffTox dose-finding design in the Matchpoint trial.An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.
P2860
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@ast
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@en
type
label
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@ast
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@en
prefLabel
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@ast
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@en
P2860
P1476
Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
@en
P2093
Koen van Besien
Nitin Jain
P2860
P304
1025-48, vi
P356
10.1016/J.HOC.2011.09.003
P577
2011-10-01T00:00:00Z